AbbVie Inc. (NYSE:ABBV) is included among the 15 Best Stocks to Buy for the Long Term. On December 10, HSBC increased its ...

AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

AbbVie Inc. (NYSE:ABBV) engages in the research and development, manufacture, and sale of medicines and therapies worldwide.

AbbVie Inc. closed 8.05% short of its 52-week high of $244.81, which the company reached on October 1st.

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other pharma stocks.

AbbVie remains a Strong Buy due to robust growth in immunology and neuroscience portfolios, offsetting Humira's decline.

AbbVie Inc.'s ( NYSE:ABBV ) dividend will be increasing from last year's payment of the same period to $1.73 on 17th ...

Piper Sandler 37th Annual Healthcare Conference December 3, 2025 8:30 AM ESTCompany ParticipantsDavid Amsellem - MD & Senior ...

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...